Acral peeling skin syndrome

Kanwarjit S. Dhillon, Deepak Sharma, Tarunveer Singh, Ritika Srivastava, Vidhi Agarwal, Sweksha Srivastava, Areeba Khan, Soni Yadav

Abstract


Acral peeling skin syndrome is a rare, congenital subtype of peeling skin syndrome affecting the dorsal and volar aspects of hands and feet. The cutaneous manifestations consist of lifelong, episodic or continuous, painless, non-inflammatory peeling of dorsal and volar aspects of hands and feet. A biopsy specimen shows hyperkeratosis and splitting of the epidermis between the granular layer and the stratum corneum. This chronic disease has no known effective established treatment.


Keywords


Acral peeling, Peeling skin syndrome

Full Text:

PDF

References


Fox H. Skin shedding (keratolysis exfoliativa congenita): report of a case. (Abstract). Arch Derm Syph.1921;3:202.

García EG, Carreño RG, Martínez González MA, Reyes JJ. Acral peeling skin syndrome: report of two cases. Ultrastruct Pathol. 2005;29(1):65-70.

Brusasco A, Veraldi S, Tadini G, Caputo R. Localized peeling skin syndrome: case report with ultrastructural study. Br J Dermatol. 1998;139(3):492-5.

Shwayder T, Conn S, Lowe L. Acral peeling skin syndrome. Arch Dermatol. 1997;133(4):535-6.

Hashimoto K, Hamzavi I, Tanaka K, Shwayder T. Acral peeling skin syndrome. J Am Acad Dermatol. 2000;43(6):1112-9.

Cassidy AJ, van Steensel MA, Steijlen PM, van Geel M, van der Velden J, Morley SM et al. A homozygous missense mutation in TGM5 abolishes epidermal transglutaminase 5 activities and causes acral peeling skin syndrome. Am J Hum Genet. 2005;77(6):909-17.

Garg K, Singh D, Mishra D. Peeling skin syndrome: Current status. Dermatol Online J. 2010;15;16(3):10.

Sarma N, Boler AK, Bhanja DC. Peeling skin syndrome in eight cases of four different families from India and Bangladesh. Indian J Dermatol Venereol Leprol. 2012;78(5):625-31.

Mizuno Y, Suga Y, Hasegawa T, Haruna K, Kohroh K, Ogawa H A case of peeling skin syndrome successfully treated with topical calcipotriol. J Dermatol. 2006;33(6):430-2.